Discovery of an indolium-based, turn-on fluorescent ligand that represses the Neuroblastoma RAS expression by targeting the 5′-UTR G-quadruplex structure

Abstract

The RNA G-quadruplex (RG4) at 5′-UTRs of Neuroblastoma RAS (NRAS) mRNA is considered to modulate the NRAS translation, providing new opportunities for interfering with NRAS hyperactivation. Therefore, targeting this RG4 structure by small molecules seems to be an alternative strategy for treating cancers with NRAS mutations or overexpression. In this study, we have developed a promising fluorescent ligand, which exhibited an extremely high fluorescence quantum yield as well as a relatively strong binding affinity with NRAS RG4. Then, this ligand was demonstrated to be able to illuminate the cellular RG4 structures. Furthermore, this ligand remarkably suppressed the translation level of NRAS mRNA, leading to the inhibition of downstream MAPK and AKT signaling pathways in NRAS-amplified MCF-7 cells. Increase of cell apoptosis as well as decrease of cell growth and migration were also detected in tumor cells treated with the ligand. Therefore, a novel and promising fluorescent ligand targeting NRAS RG4 was presented in this study, providing a potential strategy for the "undruggable" protein target.